Wilson Sonsini Goodrich & Rosati advised Sorriso Pharmaceuticals on the deal.Sorriso Pharmaceuticals, a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
